Thus, in assessing the facial skin of TSC individuals, one is looking at the most robust growth of tens to hundreds of thousands of fibroblast clones, whose growth is driven by 2-hit loss of TSC2 and likely influenced by potential cell-intrinsic and -extrinsic effects, including specific fibroblast subtype and microenvironment. This evidence concerns the gene TSC2 and tuberous sclerosis.